Hap Trading, LLC Repligen Corp Transaction History
Hap Trading, LLC
- $1.15 Trillion
- Q4 2024
A detailed history of Hap Trading, LLC transactions in Repligen Corp stock. As of the latest transaction made, Hap Trading, LLC holds 55,300 shares of RGEN stock, worth $8.79 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
55,300Holding current value
$8.79 Million% of portfolio
0.03%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding RGEN
# of Institutions
481Shares Held
56.3MCall Options Held
251KPut Options Held
458K-
Black Rock Inc. New York, NY7.57MShares$1.2 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD7.14MShares$1.13 Billion0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.1MShares$811 Million0.01% of portfolio
-
State Street Corp Boston, MA1.69MShares$269 Million0.01% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.54MShares$245 Million1.48% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $8.82B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....